Publication

Epidemiology of Depression

Jonge, de, P. & Loo, van, H., 2014, Handbook of Depression. Gotlib, I. H. & Hammen, C. L. (eds.). 3 ed. Guilford Press, p. 7-24

Research output: Chapter in Book/Report/Conference proceedingChapterProfessional

APA

Jonge, de, P., & Loo, van, H. (2014). Epidemiology of Depression. In I. H. Gotlib, & C. L. Hammen (Eds.), Handbook of Depression (3 ed., pp. 7-24). Guilford Press.

Author

Jonge, de, Peter ; Loo, van, Hanna. / Epidemiology of Depression. Handbook of Depression. editor / Ian H. Gotlib ; Constance L. Hammen. 3. ed. Guilford Press, 2014. pp. 7-24

Harvard

Jonge, de, P & Loo, van, H 2014, Epidemiology of Depression. in IH Gotlib & CL Hammen (eds), Handbook of Depression. 3 edn, Guilford Press, pp. 7-24.

Standard

Epidemiology of Depression. / Jonge, de, Peter; Loo, van, Hanna.

Handbook of Depression. ed. / Ian H. Gotlib; Constance L. Hammen. 3. ed. Guilford Press, 2014. p. 7-24.

Research output: Chapter in Book/Report/Conference proceedingChapterProfessional

Vancouver

Jonge, de P, Loo, van H. Epidemiology of Depression. In Gotlib IH, Hammen CL, editors, Handbook of Depression. 3 ed. Guilford Press. 2014. p. 7-24


BibTeX

@inbook{cfe860d65e144a6b8ac1c2be33c66a59,
title = "Epidemiology of Depression",
abstract = "Epidemiological evidence shows that major depressive disorder (MDD) is a commonly occurring, seriously impairing, and often undertreated disorder. MDD occurs in the context of a very high prevalence of depressed mood and a high prevalence of subsyndromal depressive episodes. MDD is often recurrent and is typically comorbid with other mental disorders that are usually temporally primary in the sense that first lifetime onset of MDD usually occurs after the onset of at least one other lifetime comorbid disorder. Future efforts such as the NIMH RDoC initiative will be needed to identify the neural circuitry, disease mechanisms, and critical periods underlying depression—information essential to improving our current diagnostic, therapeutic, and prevention strategies. Progress in these areas is sorely needed, as evidenced by the structural impairments that occur subsequent to the onset of MDD, including low educational attainment, poor marital outcomes, and poor socioeconomic outcomes. The day-to-day role impairments that occur in conjunction with MDD include poor performance in both productive and social roles. Increased efforts are needed to document the cost-effectiveness of expanded depression treatment and of treatment-quality improvement initiatives. Because employers play such a large part in driving health insurance benefit design in the United States, it is especially important to document the return on investment of expanded depression outreach and treatment from the employer perspective. We also need to expand research on modifiable barriers to help seeking for depression and to evaluate the effectiveness of systematic depression screening and outreach programs designed to increase the proportion of people with depression who seek treatment. (PsycINFO Database Record (c) 2016 APA, all rights reserved)",
author = "{Jonge, de}, Peter and {Loo, van}, Hanna",
year = "2014",
language = "English",
isbn = "9781462509379",
pages = "7--24",
editor = "Gotlib, {Ian H.} and Hammen, {Constance L. }",
booktitle = "Handbook of Depression",
publisher = "Guilford Press",
edition = "3",

}

RIS

TY - CHAP

T1 - Epidemiology of Depression

AU - Jonge, de, Peter

AU - Loo, van, Hanna

PY - 2014

Y1 - 2014

N2 - Epidemiological evidence shows that major depressive disorder (MDD) is a commonly occurring, seriously impairing, and often undertreated disorder. MDD occurs in the context of a very high prevalence of depressed mood and a high prevalence of subsyndromal depressive episodes. MDD is often recurrent and is typically comorbid with other mental disorders that are usually temporally primary in the sense that first lifetime onset of MDD usually occurs after the onset of at least one other lifetime comorbid disorder. Future efforts such as the NIMH RDoC initiative will be needed to identify the neural circuitry, disease mechanisms, and critical periods underlying depression—information essential to improving our current diagnostic, therapeutic, and prevention strategies. Progress in these areas is sorely needed, as evidenced by the structural impairments that occur subsequent to the onset of MDD, including low educational attainment, poor marital outcomes, and poor socioeconomic outcomes. The day-to-day role impairments that occur in conjunction with MDD include poor performance in both productive and social roles. Increased efforts are needed to document the cost-effectiveness of expanded depression treatment and of treatment-quality improvement initiatives. Because employers play such a large part in driving health insurance benefit design in the United States, it is especially important to document the return on investment of expanded depression outreach and treatment from the employer perspective. We also need to expand research on modifiable barriers to help seeking for depression and to evaluate the effectiveness of systematic depression screening and outreach programs designed to increase the proportion of people with depression who seek treatment. (PsycINFO Database Record (c) 2016 APA, all rights reserved)

AB - Epidemiological evidence shows that major depressive disorder (MDD) is a commonly occurring, seriously impairing, and often undertreated disorder. MDD occurs in the context of a very high prevalence of depressed mood and a high prevalence of subsyndromal depressive episodes. MDD is often recurrent and is typically comorbid with other mental disorders that are usually temporally primary in the sense that first lifetime onset of MDD usually occurs after the onset of at least one other lifetime comorbid disorder. Future efforts such as the NIMH RDoC initiative will be needed to identify the neural circuitry, disease mechanisms, and critical periods underlying depression—information essential to improving our current diagnostic, therapeutic, and prevention strategies. Progress in these areas is sorely needed, as evidenced by the structural impairments that occur subsequent to the onset of MDD, including low educational attainment, poor marital outcomes, and poor socioeconomic outcomes. The day-to-day role impairments that occur in conjunction with MDD include poor performance in both productive and social roles. Increased efforts are needed to document the cost-effectiveness of expanded depression treatment and of treatment-quality improvement initiatives. Because employers play such a large part in driving health insurance benefit design in the United States, it is especially important to document the return on investment of expanded depression outreach and treatment from the employer perspective. We also need to expand research on modifiable barriers to help seeking for depression and to evaluate the effectiveness of systematic depression screening and outreach programs designed to increase the proportion of people with depression who seek treatment. (PsycINFO Database Record (c) 2016 APA, all rights reserved)

M3 - Chapter

SN - 9781462509379

SP - 7

EP - 24

BT - Handbook of Depression

A2 - Gotlib, Ian H.

A2 - Hammen, Constance L.

PB - Guilford Press

ER -

ID: 120347906